Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for EYPT

Stock NameEyepoint Pharmaceuticals Inc
TickerEYPT(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS30233G2093
LEI549300QE1RU34T50MR69

Show aggregate EYPT holdings

News associated with EYPT

Brokerages Set Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Target Price at $26.86
Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has been given an average recommendation of “Buy” by the seven analysts that are presently covering the company, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have updated their coverage on the stock […] - 2025-09-22 02:42:50
Brokerages Set Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Price Target at $25.38
Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has earned a consensus recommendation of “Buy” from the eight ratings firms that are covering the firm, MarketBeat Ratings reports. Eight research analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have covered the stock in the last year […] - 2025-08-28 03:12:50
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Down After Earnings Miss
Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) gapped down before the market opened on Wednesday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $10.89, but opened at $9.82. Eyepoint Pharmaceuticals shares last traded at $10.42, with a volume of 189,142 shares trading hands. The company reported ($0.85) […] - 2025-08-08 02:44:51
Royal Bank Of Canada Begins Coverage on Eyepoint Pharmaceuticals (NASDAQ:EYPT)
Equities research analysts at Royal Bank Of Canada began coverage on shares of Eyepoint Pharmaceuticals (NASDAQ:EYPT – Get Free Report) in a research report issued on Tuesday, Marketbeat reports. The firm set an “outperform” rating and a $28.00 price target on the stock. Royal Bank Of Canada’s price objective would suggest a potential upside of […] - 2025-06-19 02:42:47
Two Sigma Advisers LP Decreases Position in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)
Two Sigma Advisers LP cut its stake in shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 37.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 104,500 shares of the company’s stock after selling 62,000 shares during […] - 2025-06-03 05:00:52
Two Sigma Investments LP Sells 103,098 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)
Two Sigma Investments LP reduced its stake in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 22.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 353,954 shares of the company’s stock after selling 103,098 shares during the quarter. Two […] - 2025-06-01 05:52:45
EyePoint Pharmaceuticals (NASDAQ:EYPT) Price Target Lowered to $26.00 at Mizuho
EyePoint Pharmaceuticals (NASDAQ:EYPT – Free Report) had its price objective decreased by Mizuho from $30.00 to $26.00 in a research note published on Friday,Benzinga reports. Mizuho currently has an outperform rating on the stock. A number of other equities analysts also recently issued reports on the stock. StockNews.com upgraded shares of EyePoint Pharmaceuticals to a […] - 2025-05-19 02:46:48
Tower Research Capital LLC TRC Cuts Stock Position in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)
Tower Research Capital LLC TRC cut its stake in shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 53.4% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 4,581 shares of the company’s stock after selling 5,241 shares during the period. Tower Research Capital LLC TRC’s holdings […] - 2025-05-15 05:38:48
Schonfeld Strategic Advisors LLC Acquires New Holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)
Schonfeld Strategic Advisors LLC acquired a new stake in shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 12,200 shares of the company’s stock, valued at approximately $91,000. Other hedge funds and other […] - 2025-05-15 04:56:50
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Shares Sold by Renaissance Technologies LLC
Renaissance Technologies LLC reduced its position in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 26.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 137,500 shares of the company’s stock after selling 49,937 shares during the period. Renaissance Technologies LLC’s holdings in […] - 2025-05-01 05:31:09
Legal & General Group Plc Boosts Stock Holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)
Legal & General Group Plc grew its position in shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 4.4% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 46,263 shares of the company’s stock after purchasing an additional 1,932 shares during the period. Legal & General Group Plc’s holdings in EyePoint Pharmaceuticals were […] - 2025-05-01 04:45:01
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives $26.63 Average Target Price from Analysts
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has received a consensus rating of “Buy” from the nine ratings firms that are presently covering the stock, MarketBeat reports. Nine analysts have rated the stock with a buy recommendation. The average 1 year price target among brokers that have updated their coverage on the stock in […] - 2025-04-25 02:52:46
Wellington Management Group LLP Acquires 5,552 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)
Wellington Management Group LLP lifted its holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 3.2% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 177,316 shares of the company’s stock after buying an additional 5,552 shares during the period. Wellington Management Group LLP’s holdings in EyePoint Pharmaceuticals were worth $1,321,000 at the […] - 2025-04-14 04:50:52
Brokerages Set EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) PT at $26.63
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has received a consensus rating of “Buy” from the nine brokerages that are currently covering the firm, MarketBeat.com reports. Nine equities research analysts have rated the stock with a buy rating. The average 1 year price objective among brokerages that have issued a report on the stock […] - 2025-03-31 02:46:59
Intech Investment Management LLC Acquires 6,137 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)
Intech Investment Management LLC boosted its holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 36.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 23,105 shares of the company’s stock after buying an additional 6,137 shares during the quarter. Intech Investment Management […] - 2025-03-28 06:30:47
China Universal Asset Management Co. Ltd. Has $108,000 Holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)
China Universal Asset Management Co. Ltd. grew its stake in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 40.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,472 shares of the company’s stock after buying an additional 4,179 shares during the quarter. China Universal […] - 2025-02-04 07:14:53

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) EYPT holdings

DateNumber of EYPT Shares HeldBase Market Value of EYPT SharesLocal Market Value of EYPT SharesChange in EYPT Shares HeldChange in EYPT Base ValueCurrent Price per EYPT Share HeldPrevious Price per EYPT Share Held
2025-11-11 (Tuesday)44,275USD 515,582USD 515,582
2025-11-10 (Monday)44,275EYPT holding increased by 114USD 502,521EYPT holding increased by 7476USD 502,521114USD 7,476 USD 11.35 USD 11.21
2025-11-07 (Friday)44,161USD 495,045EYPT holding increased by 5741USD 495,0450USD 5,741 USD 11.21 USD 11.08
2025-11-06 (Thursday)44,161EYPT holding increased by 114USD 489,304EYPT holding increased by 4126USD 489,304114USD 4,126 USD 11.08 USD 11.015
2025-11-05 (Wednesday)44,047USD 485,178EYPT holding decreased by -60564USD 485,1780USD -60,564 USD 11.015 USD 12.39
2025-11-04 (Tuesday)44,047EYPT holding increased by 115USD 545,742EYPT holding decreased by -1211USD 545,742115USD -1,211 USD 12.39 USD 12.45
2025-11-03 (Monday)43,932USD 546,953EYPT holding decreased by -28117USD 546,9530USD -28,117 USD 12.45 USD 13.09
2025-10-31 (Friday)43,932USD 575,070EYPT holding increased by 38660USD 575,0700USD 38,660 USD 13.09 USD 12.21
2025-10-30 (Thursday)43,932EYPT holding increased by 575USD 536,410EYPT holding increased by 27832USD 536,410575USD 27,832 USD 12.21 USD 11.73
2025-10-29 (Wednesday)43,357EYPT holding increased by 230USD 508,578EYPT holding decreased by -19728USD 508,578230USD -19,728 USD 11.73 USD 12.25
2025-10-28 (Tuesday)43,127USD 528,306EYPT holding increased by 6038USD 528,3060USD 6,038 USD 12.25 USD 12.11
2025-10-27 (Monday)43,127USD 522,268EYPT holding increased by 5607USD 522,2680USD 5,607 USD 12.11 USD 11.98
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EYPT by Blackrock for IE00BYXG2H39

Show aggregate share trades of EYPT

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY11411.78011.220 11.276USD 1,285 8.63
2025-11-06BUY11411.75010.860 10.949USD 1,248 8.60
2025-11-04BUY11512.95011.960 12.059USD 1,387 8.57
2025-10-30BUY57512.25011.550 11.620USD 6,682 8.51
2025-10-29BUY23011.73012.470 12.396USD 2,851 8.49
2025-10-22SELL-45611.45012.080 12.017USD -5,480 8.40 Loss of -1,650 on sale
2025-10-20BUY22812.03012.050 12.048USD 2,747 8.36
2025-10-17BUY56911.63011.660 11.657USD 6,633 8.34
2025-10-15BUY90411.73013.490 13.314USD 12,036 8.32
2025-10-03BUY80513.73014.040 14.009USD 11,277 8.27
2025-10-02BUY11513.50013.750 13.725USD 1,578 8.24
2025-09-30BUY23014.24014.910 14.843USD 3,414 8.18
2025-09-26BUY23013.90014.100 14.080USD 3,238 8.11
2025-09-25BUY23013.19014.060 13.973USD 3,214 8.08
2025-09-24SELL-2,45114.08014.380 14.350USD -35,172 8.04 Loss of -15,454 on sale
2025-09-18BUY12213.76013.970 13.949USD 1,702 8.01
2025-09-17BUY36913.64014.150 14.099USD 5,203 7.98
2025-08-20SELL-48811.51011.520 11.519USD -5,621 7.88 Loss of -1,776 on sale
2025-07-30BUY4849.84010.410 10.353USD 5,011 7.78
2025-07-17SELL-24210.30010.580 10.552USD -2,554 7.63 Loss of -708 on sale
2025-07-11SELL-97610.36011.140 11.062USD -10,797 7.56 Loss of -3,420 on sale
2025-07-07BUY3669.4909.990 9.940USD 3,638 7.48
2025-07-02BUY6,7109.66010.200 10.146USD 68,080 7.45
2025-06-11BUY2468.8109.360 9.305USD 2,289 7.36
2025-06-10BUY2489.2109.550 9.516USD 2,360 7.35
2025-06-04SELL-1248.2008.360 8.344USD -1,035 7.31 Loss of -128 on sale
2025-04-23BUY1246.7107.000 6.971USD 864 7.59
2025-04-10SELL-1,0004.8004.850 4.845USD -4,845 7.78 Profit of 2,936 on sale
2025-04-08SELL-1254.1304.860 4.787USD -598 7.86 Profit of 384 on sale
2025-04-07SELL-1254.6204.720 4.710USD -589 7.90 Profit of 398 on sale
2025-04-04SELL-6254.6105.100 5.051USD -3,157 7.94 Profit of 1,803 on sale
2025-04-01BUY4,6595.0505.390 5.356USD 24,954 8.00
2025-03-31SELL-3335.4205.710 5.681USD -1,892 8.03 Profit of 783 on sale
2025-03-14SELL-1,7926.5207.060 7.006USD -12,555 8.32 Profit of 2,348 on sale
2025-03-07SELL-2247.1307.450 7.418USD -1,662 8.40 Profit of 221 on sale
2025-03-04SELL-1126.0806.310 6.287USD -704 8.50 Profit of 247 on sale
2025-02-25BUY2245.9606.140 6.122USD 1,371 8.71
2025-02-19SELL-1126.4706.570 6.560USD -735 8.89 Profit of 261 on sale
2025-02-13BUY3336.3106.520 6.499USD 2,164 9.09
2025-02-12BUY1116.3506.440 6.431USD 714 9.14
2025-02-11BUY4446.2806.470 6.451USD 2,864 9.20
2024-12-30BUY3,9587.0207.200 7.182USD 28,426 9.94
2024-11-18SELL-1,4108.5809.310 9.237USD -13,024 11.20 Profit of 2,762 on sale
2024-11-08SELL-9411.63011.770 11.756USD -1,105 11.17 Loss of -55 on sale
2024-10-21SELL-9510.70011.200 11.150USD -1,059 0.00 Loss of -1,059 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EYPT

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19144,3110478,78130.1%
2025-09-1861,5550157,38239.1%
2025-09-17153,9580310,19449.6%
2025-09-16174,952100313,03755.9%
2025-09-15102,4272477,69321.4%
2025-09-12151,1340285,33353.0%
2025-09-11123,3120726,02917.0%
2025-09-10214,378600344,32062.3%
2025-09-09349,506701534,85965.3%
2025-09-08182,539193398,31445.8%
2025-09-05401,0291,301872,73046.0%
2025-09-04150,5270204,03373.8%
2025-09-03119,5790152,25178.5%
2025-09-0293,485600125,23274.6%
2025-08-2985,1280126,07667.5%
2025-08-28100,0920159,66062.7%
2025-08-27113,5750195,49858.1%
2025-08-2684,3773,285103,08181.9%
2025-08-25146,0670181,25880.6%
2025-08-22151,702300227,73366.6%
2025-08-21150,5090200,66475.0%
2025-08-20243,8887,193433,20956.3%
2025-08-1998,626158328,64630.0%
2025-08-18152,8387,300322,18547.4%
2025-08-15159,7870278,10557.5%
2025-08-14411,4270538,42376.4%
2025-08-13207,6064,811338,94661.3%
2025-08-12195,609704281,16069.6%
2025-08-1191,269141183,86249.6%
2025-08-08116,484424138,70584.0%
2025-08-07268,9303,232334,20080.5%
2025-08-06254,0945,239397,46263.9%
2025-08-05266,307120367,71172.4%
2025-08-04121,545710192,29263.2%
2025-08-01112,1570150,78774.4%
2025-07-31144,3730175,66882.2%
2025-07-30102,2330139,09373.5%
2025-07-2985,3940118,63972.0%
2025-07-28102,4120123,05383.2%
2025-07-2583,3250112,60574.0%
2025-07-24127,4050225,25256.6%
2025-07-2368,7510172,48639.9%
2025-07-2282,7970166,45549.7%
2025-07-21155,571408213,13473.0%
2025-07-18181,0520261,11469.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.